Source: http://www.google.es/patents/US9815240
Timestamp: 2018-01-18 06:18:12
Document Index: 769847901

Matched Legal Cases: ['Application No. 0707467', 'Application No. 0724216', 'art 125', 'Application No. 2008240418', 'Application No. 2010', 'Application No. 2010', 'Application No. 08736993']

Patente US9815240 - Expansion moulding of shape memory polymers - Google Patentes
The present invention relates to shape memory materials and to a method for controlling shape change in shape memory materials. In particular, the invention relates to a method and a system for forming complex shapes from shape memory materials and to shape memory materials having complex shapes....http://www.google.es/patents/US9815240?utm_source=gb-gplus-sharePatente US9815240 - Expansion moulding of shape memory polymers
Número de publicación US9815240 B2
Número de solicitud US 12/596,525
Número de PCT PCT/GB2008/001331
Fecha de publicación 14 Nov 2017
Número de publicación 12596525, 596525, PCT/2008/1331, PCT/GB/2008/001331, PCT/GB/2008/01331, PCT/GB/8/001331, PCT/GB/8/01331, PCT/GB2008/001331, PCT/GB2008/01331, PCT/GB2008001331, PCT/GB200801331, PCT/GB8/001331, PCT/GB8/01331, PCT/GB8001331, PCT/GB801331, US 9815240 B2, US 9815240B2, US-B2-9815240, US9815240 B2, US9815240B2
Inventores Horacio Montes de Oca Balderas, Malcolm Brown
Citas de patentes (457), Otras citas (67), Clasificaciones (11)
US 9815240 B2
The present invention relates to shape memory materials and to a method for controlling shape change in shape memory materials. In particular, the invention relates to a method and a system for forming complex shapes from shape memory materials and to shape memory materials having complex shapes.
1. A pre-relaxed three-dimensional shape memory polymer material having a molded configuration made by the method comprising:
consolidating a material including an amorphous shape memory polymer material to form an isotropic cylinder in a first configuration;
orientating the amorphous shape memory polymer material in the isotropic cylinder having the first configuration thereby forming an orientated shape memory polymer material having a second configuration;
forming a mold about the orientated shape memory polymer material having the second configuration, such that the mold constrains the first portion of the oriented shape memory polymer material and the mold does not constrain a second portion of the oriented shape memory polymer material;
applying a source of energy to, and/or exposing to at least one plastizer the orientated shape memory polymer material having the second configuration while the first portion is within the mold, thereby at least partially relaxing the orientated shape memory polymer material into a third configuration in which only the first portion conforms to the configuration of the mold and in which the first portion retains more shape memory potential than the second portion;
ceasing the application of the source of energy to the shape memory polymer material when the shape memory polymer material is formed into the third configuration; and removing the mold when the shape memory polymer material is formed into the third configuration and the application of the source of energy, and/or exposure to at least one plastizer has ceased, wherein the shape memory polymer material having the third configuration retains its configuration unless a source of energy is applied to, and/or at least one plastizer is exposed to the shape memory polymer material in the third configuration, the retention of the shape memory polymer material in the third configuration after ceasing the application of the source of energy to, and/or the exposure to at least one plasticer, and the removal of the mold being greater than the retention of a configuration formed of the same shape memory polymer material treated by the same method except for not being in a mold when at least partially relaxed, and wherein the first, second, and third configurations are different to each other, and molecular motion of the third pre-relaxed configuration is stimulated to trigger further relaxation, wherein the shape memory polymer comprises an amorphous polymer.
2. The material of claim 1, wherein the source of energy is selected from the group consisting of a magnetic field, an electric current, ultrasound, electromagnetic radiation, heat by convection, heat by conduction, radiation or any combination thereof.
3. The shape memory polymer material of claim 1, wherein the shape memory polymer is a copolymer.
4. The shape memory polymer material of claim 3, wherein the copolymer comprises a component selected from a group consisting of glycolide, lactide, ethylene glycol, or ε-caprolactone.
5. The shape memory polymer material of claim 3, wherein the copolymer includes the amorphous polymer and at least one mobile and/or rigid polymer.
6. The shape memory polymer material of claim 3, wherein the copolymer includes a semi-crystalline polymer and at least one mobile polymer and/or one rigid polymer.
7. The shape memory polymer material of claim 5, wherein the mobile polymer includes polyethylene glycol, or ε-caprolactone, or glycolide, or D,L lactide and the rigid polymer includes D-lactide or L-lactide.
8. The shape memory polymer material of claim 1, wherein the shape memory polymer includes particles such as mineral particles, or ceramic particles, or magnetic particles, or photosensitive particles, or any combination thereof.
9. The shape memory polymer material of claim 1, wherein the shape memory polymer includes one or more releasable bioactive agents.
10. The shape memory polymer material as claimed in claim 9, wherein the one or more releasable bioactive agents include bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma/solution, platelet poor plasma/solution, bone marrow aspirate, cells sourced from plants or animals.
11. The shape memory polymer material of claim 1, wherein the shape memory polymer includes a cell growth promoter.
12. The shape memory polymer material of claim 1, the method further comprising applying a source of energy to, and/or exposing to at least one plastizer the third configuration after removal of the mold thereby fully relaxing the third configuration into a fourth configuration that is substantially the same configuration as the first, configuration.
13. The shape memory polymer material of claim 12, wherein the source of energy is selected from the group consisting of a magnetic field, an electric current, ultrasound, electromagnetic radiation, heat by convection, heat by conduction, radiation or any combination thereof.
14. The shape memory polymer material of claim 1, wherein the orientating of the unorientated shape memory polymer material having a first configuration thereby forming an orientated shape memory polymer material having a second configuration comprises orientating by zone drawing, hydrostatic extrusion, die drawing, rolling, roll drawing, compression moulding, or any combination thereof.
This application is a U.S. National Stage Application, submitted under 35 U.S.C. 371, claiming priority to PCT International Patent Application PCT/GB2008/001331 filed on Apr. 16, 2008, which claims priority to Great Britain Patent Application No. 0707467.7 filed on Apr. 18, 2007 and Great Britain Patent Application No. 0724216.7 filed on Dec. 12, 2007, the disclosures of which are incorporated herein by reference in their entirety.
Shape memory polymers (SMPs) are materials that have the ability to “memorize” a “permanent” macroscopic shape, be orientated or manipulated under temperature and/or stress to a temporary or dormant shape, and then be subsequently relaxed to the original or memorized, stress-free condition or shape. Relaxation is usually prompted or encouraged by the application of thermal, electrical, or environmental energy to the manipulated or orientated SMP. This relaxation is associated with elastic deformation energy stored in the SMP during orientation of the SMP. The degree of orientation of the SMP is the driving force that causes relaxation. Thus the greater the degree of orientation, the greater will be the force or energy stored in the SMP and hence the greater will be the force or energy driving relaxation of the SMP when triggered or prompted by an external energy source.
SMPs like other polymers can be grouped into two main categories; they can be amorphous, thus lacking any regular positional order on the molecular scale, or they can be semicrystalline which contain both molecularly ordered crystalline regions and amorphous regions in the same sample.
Plastic deformation of amorphous SMPs and SMP composites results in the formation of an orientated amorphous or semi-crystalline polymer network. Orientation of SMPs and SMP composites can be achieved by stretching, drawing or applying a compressive and/or shear force to the SMP. The SMP may be orientated by application of any one or a combination of these forces and can be carried out at ambient temperatures or elevated temperatures. Generally, the temperature of the SMP is raised above ambient temperature to around the glass transition temperature (Tg) of the SMP before application of the orientation force or forces. Raising the temperature of the SMP in this way helps prevent the SMP from rupturing when the orientation force is being applied thereto. The glass transition temperature is the temperature below which the physical properties of amorphous SMPs behave in a manner similar to a solid, and above which they behave more like a rubber or liquid allowing the SMP to undergo plastic deformation without risk of fracture. After the SMP has been orientated, the temperature is reduced and the SMP is fixed in a temporary or dormant configuration.
The orientated network is physically stable well below the glass transition temperature (Tg) where molecular mobility is low. However, near or above the polymer's glass transition temperature, molecular motion rapidly increases and causes the orientated network to relax, usually accompanied by physical changes in the dimensions of the SMP. During relaxation, the orientated SMP tends to recover the original dimensions of the unorientated SMP, hence the name shape “memory” material. However, recovery of the original shape depends primarily on the degree of crystallinity, orientation, the micro and nano-structures and the conditions under which the orientated network is relaxed. For copolymers other important factors are their detailed composition and their specific thermal properties, i.e. the glass transition and melting temperatures, of their components.
It is believed that the relaxation process occurs nearly at constant volume. The degree of recovery during relaxation, for a semi-crystalline orientated SMP, depends on its crystallinity and structure and complete recovery of its original shape is difficult. In contrast, amorphous orientated SMPs, copolymers and their composites can return substantially to their original shape under appropriate relaxation conditions.
The degree of orientation is the driving force that causes relaxation. The greater the degree of orientation, i.e. the force or forces applied to the SMP, the greater will be the driving force.
During relaxation, the orientated SMP releases stored internal forces or energy. For example, an SMP of cylindrical shape orientated by applying a stretching force uniaxially along its longitudinal axis will shrink in length and expand in diameter during relaxation under free boundary conditions, i.e. where no physical constraints are imposed. Hence, when the cylindrical shaped SMP relaxes, it will induce a shrinkage force along its longitudinal axis and also an expanding force in the radial direction. These longitudinal and radial forces are proportional to the degree of orientation and mass of orientated polymer. The greater the degree of orientation, i.e. the greater the forces applied to the SMP during orientation, and the greater the mass of the SMP, the greater these longitudinal and radial relaxation forces will be. For SMPs of other geometries, the relaxation forces will also depend on the degree or magnitude of the orientation force, the direction of the applied orientation force, as well as the mass of the orientated SMP. The rate of relaxation or the rate of shape recovery of the SMP is dependent on sample geometry, processing conditions and more importantly on the mass and thermal diffusivity of the SMP.
The mechanism of the prior art whereby the shape of an SMP is altered involves applying an orientation force to the SMP. Following orientation of the SMP where the SMP is changed from a first pre-orientated shape to a second orientated shape, the orientated SMP is heated above its glass transition temperature wherein the SMP relaxes back to its original or pre-orientated shape. It is an aim of the present invention to provide a shape memory polymer with tailored relaxation characteristics, capable of relaxing back to a shape which is different to its original shape. It is a further aim of the invention to provide shape memory material with complex geometries and structural assemblies of shape memory polymers with other solid elements such as metals, polymers and ceramics.
According to a first aspect of the present invention there is provided a shape memory polymer having a first configuration and a second orientated configuration, the second orientated configuration when at least partially relaxed in a mould by stimulating molecular motion of the SMP, relaxes to a third configuration that is different to the first and second configurations.
According to a second aspect of the present invention there is further provided a method for manufacturing a pre-relaxed shape memory polymer comprising the steps of:—processing a shape memory polymer having a first configuration to form an orientated shape memory polymer having a second configuration which is different to the first configuration; at least partially relaxing the orientated shape memory polymer by stimulating molecular motion of the shape memory polymer; and controlling the conditions under which the orientated shape memory material is at least partially relaxed to form a pre-relaxed shape memory polymer having a third configuration which is different to the first and second configurations.
Generally, the term configuration refers to the shape of the SMP but may also refer solely to the dimensions of the SMP. For example, in an embodiment of the invention, the third or final shape of the SMP can be intermediate in dimension between the first shape and second orientated shape. Intermediate in dimension may refer to one or more dimensions of the shape. For example, the SMP may have an initial or first cylindrical shape having radius r and height h and may be orientated, by stretching along its longitudinal axis, to create a cylinder having a second shape with a smaller radius r−− and larger height h++. An example of an intermediate third shape would thus include a cylinder having a radius R and height H, where r−−<R<r and h<H<h++.
Preferably, the third shape is substantially different to the first and second shapes. For example, in an embodiment of the invention, the initial shape of the SMP is cylindrical and the final shape is that of a threaded screw. In another embodiment the initial shape is cylindrical and the final shape is a rod with regular polygonal cross sectional area such as, for example, a triangle, quadrilateral, or pentagon.
Preferably, the step of processing the shape memory material includes applying a stretching, or drawing or compressive force to the SMP. Typically, these forces may be applied to the SMP by zone drawing, or hydrostatic extrusion, or die drawing, or rolling, or roll drawing, or compression moulding. Alternatively any combination of these forces may be applied to the SMP
Preferably, the SMP is heated during or prior to application of the one or more of these forces to the SMP. The application of heat to the SMP prevents the SMP from rupturing which may otherwise occur on application of one or more of these forces. Preferably, the SMP is heated to, close to, or above its Tg.
Preferably, the step of processing the shape memory material includes the addition of particles to the SMP. The particles help to conduct and distribute the heat more quickly to the SMP thus reducing the heating period which would otherwise be required in a less conductive material. The particles also help distribute the heat more evenly over the SMP providing an orientated SMP which has more consistent properties throughout. Preferably, the particles include mineral particles, ceramic particles, or combinations thereof. Preferably the particles are biodegradable inorganic particles. The particles may also be magnetic or photo sensitive particles.
After processing the SMP in this way, the SMP is now orientated and thus contains trapped energy which is later released during the relaxing step. The energy released during the relaxing step helps drive the shape change of the SMP. The trapped energy of the orientated SMP is released by stimulating molecular motion of the orientated SMP.
Preferably, stimulation of molecular motion is achieved by the application of energy to the SMP from an external source. Preferably, the energy applied is in the form of heat. Preferably, the SMP is heated above the glass transition temperature (Tg) of the SMP. Alternatively or additionally, the relaxing step and thus the release of trapped energy from the SMP may be prompted or triggered by the application of a different form of energy, for example, a magnetic field, an electric current, ultrasound, electromagnetic radiation such as microwaves, visible and infrared light, or by a combination of any one of these forms of energy.
Stimulating molecular motion of the SMP may also be achieved by exposing the orientated SMP to a plasticizer. Exposure of the SMP to a plasticizer reduces the Tg of the SMP, thus increasing its molecular mobility. In this way, the molecular mobility of the orientated SMP may be increased sufficiently to cause the orientated network to relax. Where exposure of the orientated SMP to a plasticizer is not sufficient to relax the SMP, energy, in the form of heat for example, may also be applied to the SMP. In this way, the orientated SMP can be relaxed at a temperature less than would be necessary where the SMP is relaxed using heat alone. As such, the SMP can be shaped at lower temperatures, thus allowing the addition of temperature sensitive materials to the SMP. Temperature sensitive materials may include, for example, releasable bioactive agents such as monobutyrin, bone marrow aspirate, angiogenic and osteogenic factors.
Plasticizers may be in the form of a volatile liquid or a gas. Examples of gaseous plasticizers include but are not limited to, oxygen, nitrogen, carbon dioxide, sulphur dioxide, ammonia, methane, ethane, butane, propane, hexane, decane, ethene, propene, butene, hexene, dodecanene, ethyne, and butyne. Examples of liquid plasticizers include but are not limited too, water, inorganic aqueous solutions such as sodium chloride solution, cyclic alkanes, such as cyclohexane and methylcyclohexane, cyclic alkenes, such as benzene and toluene, cyclic alkynes, halogen substitute alkanes, alkenes, and alkynes, such as carbon tetrachloride and chloropropane, oxygen substituted hydrocarbons, such as ethylene oxide and ethoxy hexane, aldehydes, such as hexanal, ketones, such as cyclohexanone, alcohols, such as methanol and ethanol, esters, such as buylpropionate, nitrogen substituted hydrocarbons, such as amine-triethylamine, and sulphur substituted hydrocabons, such as butane thiol and diethyl sulphide.
The energy stored in the SMP can either be completely released or partially released leading to a completely relaxed or partially relaxed SNAP. The resulting SMP is then known as a pre-relaxed SNAP. Once the SNAP is fully relaxed it can not be further relaxed unless reprocessed or re-orientated.
Ideally, the step of controlling the conditions under which the orientated SMP is at least partially relaxed includes placing at least part of the orientated SMP in a mould. The shape of the mould determines the third or final shape of the SMP and prevents the SNAP from returning to its original or first shape.
The mould may be of similar dimensions to the second shape and thus restrict the polymer to a third shape very similar to the second shape. Alternatively the mould may be of different dimensions, thus allowing the polymer to relax to a third shape substantially different to the first and second shapes. Complex moulds can be used to form pre-relaxed SMPs with complex shapes.
Where a plasticizer is used to relax the orientated SMP instead of or in addition to the application of energy, the mould may be porous or perforated, for example, to allow the direct contact of the orientated SMP with the plasticizer.
The step of controlling the conditions under which the orientated shape memory material is at least partially relaxed may also include control of the energy added to the SMP when relaxing the orientated SMP. Where heat is used as the energy source, variations in the temperature and period of exposure will result in shaped SMP having different properties. For example, where the SMP is exposed to heat for a short period of time, the SMP, although it will have formed ifs final shape within the mould, will have only given up part of its trapped energy and thus only have partially relaxed. Such a shaped SMP will be capable of further relaxing. This is particularly advantageous where it may be necessary to alter the dimensions, but not necessarily the overall shape, of the final shaped SMP. For example, where the final SMP is in the shape of a fastening bolt having a screw thread. In this case, the dimensions of the final fastening bolt shape can be altered somewhat to cater for dimension tolerances in a nut having a threaded receiving bore thus providing a bolt which can be more securely fitted in such a threaded bore.
Varying the orientation and relaxation of different sections of the SMP will also help tailor the final shape of the SMP.
When a final shape is required having unalterable dimensions, the SMP, whilst in the mould, can be exposed to heat for a longer period of time ensuring that the orientated SMP has released all its trapped energy and is thus fully relaxed. The addition of further energy or the further subsequent heating of such a relaxed SMP will not alter its dimensions. This is particularly useful when a device of exact and fixed shape and dimensions is required regardless of whether it may be subjected to external energy sources, such as heat, when used.
The particles added to the polymer during the processing step also help control the conditions under which the orientated SMP is at least partially relaxed. The particles help conduct the heat or other applied energy more evenly through the SMP, ensuring that the relaxing is consistent throughout the SMP, thus producing a pre-relaxed SMP having consistent properties throughout. The particles also help reduce the processing and controlling times by conducting the heat or other applied energy more quickly through the SMP than would otherwise occur. The addition of particles also helps improve subsequent machining of the shaped SMP where desired.
Generally, the larger the size of the particles added to the SMP, the longer it will take the orientated SMP to relax. This longer relaxation time could advantageously be used to tailor the shape of the relaxing SMP as the processing time is increased.
Suitable particles include but are not limited to inorganic particles such as buffers, radiopaque agents, osteoconductive agents, calcium, sodium, potassium, magnesium, barium, zirconium, bismuth, silver, gold, copper, zinc or any combination thereof. Preferably, the particles are crystalline calcium, sodium, zirconium, bismuth, barium, silicon, tungsten or magnesium salt.
Optionally, the particles can be calcium carbonate, calcium hydrogen carbonate, calcium phosphate, dicalcium phosphate, tricalcium phosphate, magnesium carbonate, sodium carbonate, hydroxyapatite, bone, phosphate glass, silicate glass, magnesium phosphate, sodium phosphate, barium sulphate, barium carbonate, zirconium sulphate, zirconium carbonate, zirconium dioxide, bismuth trioxide, bismuth oxychloride, bismuth carbonate, tungsten oxide or any combination thereof.
The particles can have a range of sizes and geometries. For example, the particles may be the shape of a needle, cube, platelet, fibre or sphere. Preferably the particles are shaped to enhance the mechanical properties of the SMP. The particle size is typically between 10 nm and 1 mm.
Typically, inorganic particles that act as buffers improve strength retention of degradable systems by reacting with the acidic breakdown products of the amorphous SMP.
Typical radiopaque agents include barium sulphate, barium carbonate, zirconium sulphate, zirconium carbonate, zirconium dioxide, bismuth trioxide, bismuth oxychloride, bismuth subcarbonate and tungsten oxide.
Typical osteogenic agents include calcium carbonate, calcium phosphate, dicalcium phosphate, tricalcium phosphate, hydroxyapatite, bone, phosphate glasses, silicate glasses, magnesium phosphate and sodium phosphate.
The particles may be pre-treated with a coupling agent such as a fatty acid, fatty acid anhydride or siloxane in order to enhance the properties of the SMP.
The method, useful for producing shape memory materials with complex geometries, is also useful for producing structural assemblies of shape memory polymers with other solid elements such as metals, polymers and ceramics.
According to another aspect of the present invention, there is provided a system for manufacturing a pre-relaxed shape memory polymer comprising a shape memory polymer as hereinbefore described and a mould.
Preferably, the mould is a complex mould for forming complex shapes of the shape memory polymer.
Preferably, the cavity of the mould has a modified surface to determine when the shape memory polymer has at least partially relaxed to form the third configuration. For example, the modified surface of the cavity can be pressure sensitive. In this way, as soon as the SMP has relaxed to form the third configuration or shape, the shaped SMP can be removed from the mould. This ensures that the SMP is relaxed for the minimum period of time resulting in a partially relaxed SMP which can be further relaxed at a later stage if required.
Generally, the SMP can be modified to produce particular desirable characteristics. The desired characteristics will depend largely on the end use of the pre-relaxed shape memory polymer.
Therefore, according to yet a further aspect of the present invention, there is provided a device including the pre-relaxed SMP as hereinbefore described.
The SMP can be of a resorbable, amorphous polymer composition or a non-resorbable, amorphous polymer composition. The SMP can be a homo polymer or a co-polymer, both of which can be linear, branched or cross-linked. The copolymer may comprise a component selected from a group consisting of glycolide, lactide, ethylene glycol or ε-caprolactone. For example, the copolymer can include a polylactide-co-glycolide, such as Poly(D,L-lactide-co-glycolide), or poly(methyl methacrylate), or poly(ethyl methacrylate) or other amorphous acrylic based polymers and copolymers. The copolymer can include an amorphous polymer composition and at least one mobile polymer and/or one rigid polymer.
Alternatively, the copolymer may include a semi-crystalline polymer and at least one mobile polymer and/or one rigid polymer. The mobility of a polymer refers to its ability to soften on application of heat. An SMP may have different areas of mobility relating to the different polymer compositions at different locations along the SMP composite. This allows different parts of the SMP to be orientated and relaxed at different temperatures and rates, thus allowing a finer control or tailoring of the final shape to be exercised. A rigid polymer is a polymer which demonstrates less mobility than a mobile polymer. The mobile polymer can include polyethylene glycol, or ε-caprolactone, or glycolide, or D,L lactide and the rigid polymer can include D-lactide or L-lactide. The co-polymer can be a random arrangement of monomers or a repetitive and sequenced arrangement of monomers.
Examples of synthetic degradable SMP material include but are not limited to polyhydroxy acids, including polylactide (PLA) based homo and co-polymers such as poly(L-lactic acid) (PLLA), poly(D-lactic acid) (PDLA), poly(D,L-lactic acid) (PDLLA), PLLA-co-PDLLA, PLLA-co-PGA (where PGA is polyglycolide), PDLA-co-PGA, PDLLA-co-PGA, PLLA-co-PCL (where PCL is ε-polycaprolactone), PDLLA-co-PCL, PDLA-co-PCL. Co-polymers with poly(ethyleneglycol) (PEG) such as PLLA-co-PEG, PDLA-co-PEG, PDLLA-co-PEG are also suitable examples of synthetic degradable SMP material. Further examples include co-polymers containing three or more of the following blocks: PLA, PEG, PCL or PGA. Polyanhydrides, poly(hydroxybutyric acid), poly(hydroxyvaleric acid), poly(pseudo aminoacids), poly(hydroxyalkanoate) and blends and co-polymers thereof.
Examples of natural biodegradable SMP material include but are not limited to polysaccharides such as alginate, dextran, cellulose, collagen, and chemical derivatives thereof. Further examples include substitutions and additions of chemical groups such as, for example, alkyl, alkylene, hydroxylations, oxidations, and other modifications routinely made by those skilled in the art. Proteins such as abumin, zein and co-polymers and blends thereof, alone or in combination with synthetic polymers are also suitable examples of natural biodegradable SMP material.
Examples of synthetic SMP material include but are not limited to polyphosphazenes, poly(vinyl alcohols), polyamides, polyester amides, poly(amino acids), polyanhydrides, polycarbonates, polyalkylenes, polyacrylamides, polyalkylene glycols, polyalkylene oxides, polyalkylene terephtalates, polyortho esters, polyvinyl ethers, poly vinyl esters, poly vinil halides, polyvinylpyrrolidone, polyesters, polysiloxanes, polyurethanes, polyacrylates such as poly(methyl methacrylate), poly(ethyl methacrylate), poly(butyl methacrylate), poly(isobutyl methacrylate), poly(phenyl methacrylate), poly(methyl acrylate), poly(isopropyl acrylate), poly(isobutyl acrylate) and poly(octadecyl acrylate), and co-polymers thereof. Further examples include poly(ethylene terephthalate), poly(ethylene), polystyrene, polycarbonate, polysulfones, polyethersulfone, polyetherimide and polypropylene.
Examples of synthetically modified natural SMP material include but are not limited to cellulose derivatives such as alkyl celluloses, hydroxyalkyl cellulose, cellulose ethers, cellulose esters, nitrocelluloses and chitosan. Examples of cellulose derivatives include methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxybutyl methyl cellulose, cellulose acetate, cellulose propionate, cellulose acetate butyrate, cellulose acetate phthalate, carboxymethyl cellulose, cellulose triacetate and cellulose sulphate sodium salt.
The SMP can include a releasable bioactive agent. These agents are included to help promote bone regrowth. Examples include bone morphogenic proteins, antibiotics, anti-inflammatories, angiogenic factors, osteogenic factors, monobutyrin, thrombin, modified proteins, platelet rich plasma/solution, platelet poor plasma/solution, bone marrow aspirate, and any cells sourced from flora or fauna, such as living cells, preserved cells, dormant cells, and dead cells. Other bioactive agents known to one of ordinary skill in the art may also be used. Alternatively or additionally, the SMP can include a porogen, such as sodium chloride. This is particularly useful where the SMP device is required to promote cell growth.
The accompanying drawings, which are incorporated in and form a part of the specification, illustrate embodiments of the present invention and together with the written description serve to explain the principles, characteristics, and features of the invention. In the drawings:
FIGS. 1A to 1D show a schematic illustration of a method, according to the present invention, for manufacturing a pre-relaxed shape memory polymer device in the form of a threaded screw;
FIGS. 2A to 2E show a schematic illustration of a method, according to the present invention, for manufacturing a pre-relaxed shape memory polymer device in the form of a cylindrical rod;
FIG. 3 is a graph showing the effect of different relaxing times on the expansion force along the radial direction of die-drawn shape memory polymer cylindrical shaped rods;
FIGS. 4A to 4D show a schematic illustration of a method, according to the present invention, for manufacturing a pre-relaxed shape memory polymer device of square cross section; and
FIGS. 5A to 5D show a schematic illustration of a method, according to the present invention, for manufacturing a pre-relaxed shape memory polymer device of triangular cross section.
The following description of preferred embodiments is merely exemplary in nature and is in no way intended to limit the invention, its application, or uses.
Preparation of Orientated Shape Memory Polymer
The following description is given by way of example only of an embodiment of processing a SMP according to the present invention to form an orientated SMP and with reference to the examples describing embodiments of how the orientated SMP can be relaxed in a controlled manner to form a pre-relaxed SMP according to the invention.
In this embodiment the SMP, amorphous poly(D,L lactide-co-glycolide), was mixed with 35% w/w CaCO3 particles (PLC). The mixture was prepared in a twin screw extruder to form fibres of the mixture. The fibres were palletised and consolidated to form isotropic cylindrical rods 110, 210, 410, and 510 with various diameters ranging from 5 mm to 20 mm using a ram extrusion technique. Isotropic rods thus formed having diameters of 5 mm, 18 mm and 20 mm were orientated by die drawing using a conical die at 60° C. and a drawing speed of 20 mm/min to form orientated rods 120, 220, 420 and 520 having diameters of 3 mm, 8 mm and 9 mm, respectively.
A prepared orientated SMP as described above in the form of a cylindrical rod 120 having a diameter of 8 mm was placed into a mould 130 having a threaded screw shaped cavity such that an end part 125 of the orientated rod 120 protrudes from an end of the mould 130. The mould 130 and orientated rod 120 are immersed in a water bath at 80° C. for 60 seconds and then into a water bath at 20° C. for another 60 seconds to allow the oriented SMP to relax, resulting in a pre-relaxed screw 140 that has a head portion 150, which expanded freely without the mechanical restraint of the mould 130, having a radius similar to the isotropic rod 110, and a threaded portion 160 having dimensions determined by the dimensions of the mould 130. On removal of the screw 140 from the mould, the addition of further energy to the threaded portion will cause the threaded portion 160 of the screw 140 to further relax and expand radially whilst the head portion 150 will remain substantially of the same radius. Both threaded portion 160 and head portion 150 will remain substantially the same shape. This expansion moulding technique can be applied to other mould geometries.
A sample of prepared orientated SMP as described above in the form of a cylindrical rod 220 having a diameter of 3 mm was placed into a mould 230 having a cylindrical cavity that has substantially the same cavity radius as the radius of the orientated rod 220. The orientated rod 220 was partially relaxed by heating the mould 230 and orientated rod 220 in a fan assisted oven at 80° C. for 5 minutes to produce a pre-relaxed cylindrical rod 240 that has substantially the same radius as the orientated cylindrical rod 220. The pre-relaxed cylindrical rod 240 is subsequently immersed in water at 80° C. to allow further relaxation without mechanical constraints. The partially relaxed rod 240 was immersed in the water until the diameter of the rod 240 did not appreciably change resulting in a twice-relaxed cylindrical rod 250 having a radius greater than the orientated cylindrical rod 220 but less than isotropic cylindrical rod 210.
This process was repeated with further sample rods 220 with partial relaxing times from 0 to 120 minutes. It was found that the degree of recovery of the original diameter of the isotropic cylindrical rod 210 decreased with increased partial relaxing time as can be seen from table 1. It was concluded that by partially relaxing the oriented rods 220 into a suitable mould the degree of recovery of the initial shape, in this case length and diameter, of the isotropic cylindrical rod 210 can be varied from substantially 0% for long partial relaxing times where the orientated rod 220 is substantially fully relaxed to almost 100% for short partial relaxing times where the orientated rod 220 is practically not relaxed at all but still contains substantially all the energy imparted thereto by orientation.
Table 1: Effect of partial relaxation time at 80° C.
on the degree of recovery of die drawn PLC rods.
Pre-relaxation Diameter of Diameter of fully
time relaxed rod pre-relaxed rod Degree of recovery
(min) (mm) (mm) (%)
0 3.05 5.20 100
5 3.05 5.20 100
15 3.05 5.20 100
20 3.05 4.35 60
30 3.05 3.65 28
60 3.05 3.17 5
120 3.05 3.09 2
FIG. 3 shows a graph plotting the expansion force in Newtons (N) against time for samples of prepared orientated SMP as described above in the form of cylindrical rods having a diameter of 3 mm. Some of the samples were partially relaxed in a two piece long metal mould having a cylindrical cavity 3 mm in diameter at 80° C. with a fan assisted oven for different periods of time and other samples were not relaxed at all. On further relaxing these cylindrical samples at 60° C., the expansion force along the radial direction of the cylindrical samples was measured for specimens having the same volume and partially relaxed for 0, 1 and 3 minutes. The graph shows that the orientated sample rods which had not been partially relaxed have a greater expansion force than the partially relaxed orientated sample rods. The expansion force of the sample rod was observed to decrease with an increase in time spent partially relaxing the sample rod. For example, 1 minute spent partially relaxing a sample rod in the mould significantly reduced the expansion force of the sample rod when further relaxed, whilst 3 minutes spent partially relaxing a sample rod in the mould reduced the expansion force yet further. It was concluded that the maximum expansion force rapidly decreases due to molecular re-arrangement of the oriented network.
A prepared orientated SMP as described above in the form of a cylindrical rod 420 having a diameter of 9 mm is placed in a cavity mould 430. The cavity of the mould 430 has a 14 mm by 14 mm square cross-section. The mould 430 and orientated rod 420 are immersed in hot water at 80° C. for 2 minutes to allow the orientated rod 420 to relax to produce a pre-relaxed bar 440 shorter in length than the cylindrical rod 420 and with a square cross section having substantially the same dimensions as the square cross-section of the cavity of the mould 430. The pre-relaxed bar 440 is clearly illustrated in FIG. 4D.
A prepared orientated SMP as described above in the form of a cylindrical rod 520 having a diameter of 9 mm is placed in a cavity mould 530. The cavity of the mould 530 has a 16 mm equilateral triangle cross-section. The mould 530 and orientated rod 520 are immersed in hot water at 80° C. for 2 minutes to allow the orientated rod 520 to relax to produce a pre-relaxed SMP 540 shorter in length than the cylindrical rod 520 and having a triangular cross section with substantially the same dimensions as the triangular cross-section of the cavity of the mould 530. The pre-relaxed SMP 540 is clearly illustrated in FIG. 5D.
Where plasticisers are used instead of or in addition to energy, the plasticiser must come into direct contact with the SMP. This can be achieved, for example, by employing a porous or perforated type mould. On introduction of the porous mould containing the orientated SMP into an environment containing a plasticiser, the plasticiser will pass through the mould via the pores and directly contact the orientated SMP to stimulate molecular motion and thus relaxation of the orientated SMP. It will be appreciated that energy in the form of heat for example, may also be used in conjunction with the plasticiser to promote relaxation of the orientated SMP. For example, the plasticiser itself may be used to transfer energy to the SMP by heating the plasticiser.
US3736646 18 Oct 1971 5 Jun 1973 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US3856905 22 Sep 1972 24 Dic 1974 Dow Chemical Co Oriented plastic tube
US3926459 13 Dic 1973 16 Dic 1975 Jacques Pontigny Dilatable tube, method for its production and applications thereof
US4559945 21 Sep 1984 24 Dic 1985 Ethicon, Inc. Absorbable crystalline alkylene malonate copolyesters and surgical devices therefrom
US4636215 11 Ene 1984 13 Ene 1987 Rei, Inc. Combination tray and condylar prosthesis for mandibular reconstruction and the like
US4700704 12 Ago 1985 20 Oct 1987 Ethicon, Inc. Surgical articles of copolymers of glycolide and ε-caprolactone and methods of producing the same
US4916207 15 Ago 1988 10 Abr 1990 Allied-Signal, Inc. Polycarbonate homopolymer-based fiber compositions and method of melt-spinning same and device
US4950258 25 Ene 1989 21 Ago 1990 Japan Medical Supply Co., Ltd. Plastic molded articles with shape memory property
US5061181 11 Ago 1989 29 Oct 1991 Core-Vent Corporation Dental implant including plural anchoring means
US5108289 10 Abr 1991 28 Abr 1992 Sekio Fukuyo Dental endosseous implant
US5110852 27 Oct 1988 5 May 1992 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
US5201771 15 Sep 1989 13 Abr 1993 Belykh Sergei I Endoprosthesis of the hip joint
US5208305 17 Abr 1992 4 May 1993 Minnesota Mining And Manufacturing Company Fluorine-containing polymers and preparation and use thereof
US5266608 27 Jun 1991 30 Nov 1993 Technion Research & Dev't Foundation, Ltd. Biomedical adhesive compositions
US5294395 12 May 1993 15 Mar 1994 Ethicon, Inc. Thermal treatment of theraplastic filaments for the preparation of surgical sutures
US5360448 19 Ene 1993 1 Nov 1994 Thramann Jeffrey J Porous-coated bone screw for securing prosthesis
US5376120 21 Oct 1992 27 Dic 1994 Biomet, Inc. Biocompatible implant and method of using same
US5383931 3 Ene 1992 24 Ene 1995 Synthes (U.S.A.) Resorbable implantable device for the reconstruction of the orbit of the human skull
US5407445 19 May 1993 18 Abr 1995 Cytrx Corporation Gel composition for implant prosthesis and method of use
US5437918 4 Nov 1993 1 Ago 1995 Mitsui Toatsu Chemicals, Inc. Degradable non-woven fabric and preparation process thereof
US5525706 25 Oct 1994 11 Jun 1996 Cargill, Incorporated Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof
US5567431 13 Mar 1992 22 Oct 1996 Centre National De La Recherche Scientifique (Cnrs) Polylactic acid-based implant susceptible of bioresorption containing and antibiotic
US5571193 11 Jun 1992 5 Nov 1996 Kampner; Stanley L. Implant with reinforced resorbable stem
US5571204 13 Jul 1995 5 Nov 1996 Merck Patent Gesellschaft Mit Beschrankter Haftung Femoral prosthesis
US5633002 4 May 1995 27 May 1997 Boehringer Ingelheim Gmbh Implantable, biodegradable system for releasing active substance
US5660846 2 Jun 1995 26 Ago 1997 Societe De Conseils De Recherches Et D'applications Scientifiques Methods and apparatus for the delivery of solid drug compositions
US5665831 10 Ago 1995 9 Sep 1997 Peter Neuenschwander Biocompatible block copolymer
US5700901 11 Ene 1995 23 Dic 1997 Boehringer Ingelheim Kg Resorbable mouldings and process for producing them
US5741329 21 Dic 1994 21 Abr 1998 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US5817328 3 Abr 1996 6 Oct 1998 Cambridge Scientific, Inc. Material for buffered resorbable internal fixation devices and method for making same
US5837276 2 Sep 1994 17 Nov 1998 Delab Apparatus for the delivery of elongate solid drug compositions
US5853639 18 Abr 1997 29 Dic 1998 Kureha Kagaku Kogyo K.K. Oriented polyglycolic acid film and production process thereof
US5863297 8 Oct 1996 26 Ene 1999 Osteobiologics, Inc. Moldable, hand-shapable biodegradable implant material
US5904658 22 Ago 1997 18 May 1999 Osteobiologics, Inc. Hand-held materials tester
US5908918 26 May 1998 1 Jun 1999 Chronopol, Inc. Impact modified polylactide
US5935172 28 Jun 1996 10 Ago 1999 Johnson & Johnson Professional, Inc. Prosthesis with variable fit and strain distribution
US5939453 4 Jun 1998 17 Ago 1999 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US5951288 3 Jul 1998 14 Sep 1999 Sawa; Shlaimon T. Self expanding dental implant and method for using the same
US5977204 11 Abr 1997 2 Nov 1999 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US5997580 6 May 1997 7 Dic 1999 Johnson & Johnson Professional, Inc. Cement restrictor including shape memory material
US5997582 1 May 1998 7 Dic 1999 Weiss; James M. Hip replacement methods and apparatus
US6001101 13 Ene 1997 14 Dic 1999 Depuy France Screw device with threaded head for permitting the coaptation of two bone fragments
US6005161 7 Jun 1995 21 Dic 1999 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US6071982 18 Abr 1997 6 Jun 2000 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
US6136369 23 Abr 1999 24 Oct 2000 Isotis B.V. Device for incorporation and release of biologically active agents
US6150497 13 Ene 1999 21 Nov 2000 Sherwood Services Ag Method for the production of polyglycolic acid
US6156842 10 Mar 1999 5 Dic 2000 The Dow Chemical Company Structures and fabricated articles having shape memory made from α-olefin/vinyl or vinylidene aromatic and/or hindered aliphatic vinyl or vinylidene interpolymers
US6162225 26 Oct 1998 19 Dic 2000 Musculoskeletal Transplant Foundation Allograft bone fixation screw method and apparatus
US6179842 22 Jun 1999 30 Ene 2001 Sulzer Orthopaedie Ag Blocking system for the medullary canal of a tubular bone
US6203573 21 Ene 1999 20 Mar 2001 Osteobiologics, Inc. Method of making biodegradable implant material and products made therefrom
US6248430 10 Ago 1999 19 Jun 2001 Dainippon Ink And Chemicals, Inc. Lactic acid-based polymer laminated product and molded product
US6277390 27 Sep 1999 21 Ago 2001 Sulzer Orthopaedie Ag UHMW polyethylene for implants
US6293950 15 Ene 1999 25 Sep 2001 Luitpold Pharmaceuticals, Inc. Resorbable pin systems
US6344496 5 Oct 1999 5 Feb 2002 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US6375465 19 Ene 1998 23 Abr 2002 Nobel Biocare Ab Bone-anchoring element
US6436136 19 Oct 1998 20 Ago 2002 Artimplant Ab Shaped bodies for use as implants in human medicine and method for the production of such shaped bodies
US6447515 21 Jun 2000 10 Sep 2002 Russell Meldrum Bioresorbable implant for fracture fixation
US6468277 4 Abr 2000 22 Oct 2002 Ethicon, Inc. Orthopedic screw and method
US6486296 25 May 1999 26 Nov 2002 Gunze Limited Lactide-containing polymer and medical material
US6488938 30 Dic 1999 3 Dic 2002 Santen Pharmaceutical Co., Ltd. Polylactic acid scleral plug
US6503278 27 Sep 1996 7 Ene 2003 Bionx Implants Oy Under tissue conditions degradable material and a method for its manufacturing
US6511511 25 Oct 1999 28 Ene 2003 Osteobiologics, Inc. Fiber-reinforced, porous, biodegradable implant device
US6579533 30 Nov 1999 17 Jun 2003 Bioasborbable Concepts, Ltd. Bioabsorbable drug delivery system for local treatment and prevention of infections
US6583232 5 Jul 1999 24 Jun 2003 Smith & Nephew Plc Blend of bioresorbable polymers
US6613089 25 Oct 2000 2 Sep 2003 Sdgi Holdings, Inc. Laterally expanding intervertebral fusion device
US6652582 8 Oct 1999 25 Nov 2003 Boston Scientific Scimed, Inc. Bioabsorbable endoprosthesis having porosity for by-product collection
US6719935 5 Ene 2001 13 Abr 2004 Howmedica Osteonics Corp. Process for forming bioabsorbable implants
US6841111 31 Ago 2001 11 Ene 2005 Basf Corporation Method for making a polyurea-polyurethane composite structure substantially free of volatile organic compounds
US6852825 17 Abr 2003 8 Feb 2005 Mnemoscience Gmbh Polyester urethanes
US6881766 7 Feb 2003 19 Abr 2005 Tyco Healthcare Group Lp Sutures and coatings made from therapeutic absorbable glass
US6951956 25 Abr 2002 4 Oct 2005 Kureha Kagaku Kogyo K.K. Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof
US6974862 20 Jun 2003 13 Dic 2005 Kensey Nash Corporation High density fibrous polymers suitable for implant
US7208550 10 Oct 2003 24 Abr 2007 The University Of Connecticut Blends of amorphous and semicrystalline polymers having shape memory properties
US7214765 8 Jul 2005 8 May 2007 Kensey Nash Corporation High density fibrous polymers suitable for implant
US7261734 23 Abr 2002 28 Ago 2007 Boston Scientific Scimed, Inc. Resorption-controllable medical implants
US7268205 16 Ene 2007 11 Sep 2007 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US7335375 21 Jun 2005 26 Feb 2008 Boston Scientific Scimed, Inc. Controlling resorption of bioresorbable medical implant material
US7378144 17 Feb 2004 27 May 2008 Kensey Nash Corporation Oriented polymer implantable device and process for making same
US7553923 26 Oct 2007 30 Jun 2009 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US8501215 28 Jul 2003 6 Ago 2013 Guohua Chen Injectable multimodal polymer depot compositions and uses thereof
US20010012940 8 Ene 2001 9 Ago 2001 Tunc Deger C. Bioabsorbable materials and medical devices made therefrom
US20010018614 28 Dic 2000 30 Ago 2001 Bianchi John R. Implants for orthopedic applications
US20020022588 22 Dic 2000 21 Feb 2002 James Wilkie Methods and compositions for sealing tissue leaks
US20020029043 3 Ago 2001 7 Mar 2002 Michael Ahrens Bone screw
US20020082362 6 Sep 2001 27 Jun 2002 Brocchini Stephen J. Degradable polyacetal polymers
US20020120348 21 Dic 2000 29 Ago 2002 Melican Mora Carolynne Reinforced tissue implants and methods of manufacture and use
US20020138154 21 Mar 2001 26 Sep 2002 Jianmin Li Controlling resorption of bioresorbable medical implant material
US20020143403 2 Ene 2002 3 Oct 2002 Vaidyanathan K. Ranji Compositions and methods for biomedical applications
US20020150775 10 Sep 1999 17 Oct 2002 Masahiro Ishikawa Degradable laminated body and a method for the preparation thereof
US20020160032 23 Feb 2001 31 Oct 2002 Marc Long Manufacture of bone graft substitutes
US20030045941 22 Ago 2002 6 Mar 2003 Lewallen David G. Coated prosthetic implant
US20030055198 8 May 2002 20 Mar 2003 Mnemoscience Gmbh Shape memory polymers
US20030104031 25 Nov 2002 5 Jun 2003 Francis Dumont Controlled release polymeric compositions of bone growth promoting compounds
US20030114937 28 Ene 2003 19 Jun 2003 Leatherbury Neil C. Biodegradable polymeric film
US20030120280 20 Dic 2001 26 Jun 2003 Roller Mark B. Bioabsorbable coatings of surgical devices
US20030125745 8 Oct 2002 3 Jul 2003 Bio One Tech Inc. Bone-fixing device
US20030130742 13 Dic 2002 10 Jul 2003 Connelly Patrick R. Apparatus for replacing musculo-skeletal parts
US20030236573 13 Jun 2002 25 Dic 2003 Evans Douglas G. Devices and methods for treating defects in the tissue of a living being
US20040002770 2 Jun 2003 1 Ene 2004 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
US20040015187 18 Abr 2003 22 Ene 2004 Mnemoscience Corporation Biodegradable shape memory polymeric sutures
US20040019386 27 Jun 2003 29 Ene 2004 Ferree Bret A. Arthroplasty devices configured to reduce shear stress
US20040052992 15 Ago 2003 18 Mar 2004 Adele Boone Biodegradeable shrink wrap
US20040054372 24 Jul 2003 18 Mar 2004 Btg International Limited Biodegradable composites
US20040106734 31 Ene 2003 3 Jun 2004 John Rose High strength bioresorbables containing poly-glycolic acid
US20040109823 19 Sep 2003 10 Jun 2004 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
US20040115239 22 Sep 2003 17 Jun 2004 Shastri Venkatram P. Engineering of material surfaces
US20040131681 5 Sep 2003 8 Jul 2004 Ambrose Catherine G. Antibiotic microspheres for treatment of infections and osteomyelitis
US20040143221 27 Dic 2003 22 Jul 2004 Shadduck John H. Biomedical implant for sustained agent release
US20040153075 10 Jul 2002 5 Ago 2004 Roger Gregory James Surgical fixation device
US20040156878 11 Feb 2003 12 Ago 2004 Alireza Rezania Implantable medical device seeded with mammalian cells and methods of treatment
US20040172118 12 Mar 2002 2 Sep 2004 Peter Gibson Laminated electrode for a cochlear implant
US20040241203 21 Jun 2002 2 Dic 2004 Shakesheff Kevin Morris Porous matrix comprising cross-linked particles
US20040242722 3 Jul 2002 2 Dic 2004 John Rose Biodegradable polymer systems
US20040254639 28 Mar 2003 16 Dic 2004 Zhigang Li Reinforced implantable medical devices
US20040258732 20 Nov 2002 23 Dic 2004 Yasuo Shikinami Implant material and process for producing the same
US20040259972 20 Jun 2003 23 Dic 2004 Ringeisen Timothy A. High density fibrous polymers suitable for implant
US20040260398 10 Feb 2004 23 Dic 2004 Kelman David C. Resorbable devices
US20040265385 3 May 2004 30 Dic 2004 Therics, Inc. Porous biostructure partially occupied by interpenetrant and method for making same
US20040267263 24 Jun 2003 30 Dic 2004 Ethicon, Inc. Porous resorbable graft fixation pin
US20050008672 12 Dic 2003 13 Ene 2005 John Winterbottom Formable and settable polymer bone composite and method of production thereof
US20050013793 16 Ene 2004 20 Ene 2005 Beckman Eric J. Biodegradable polyurethanes and use thereof
US20050033295 8 Ago 2003 10 Feb 2005 Paul Wisnewski Implants formed of shape memory polymeric material for spinal fixation
US20050080489 28 Ago 2003 14 Abr 2005 Estes Bradley T. Laterally expanding intervertebral fusion device
US20050085313 1 Oct 2004 21 Abr 2005 Bridgestone Sports Co., Ltd. Golf club head
US20050090861 27 Oct 2003 28 Abr 2005 Scimed Life Systems, Inc. Vaso-occlusive devices with in-situ stiffening elements
US20050107886 20 Dic 2002 19 May 2005 Paul Crabtree Hinged joint system
US20050136764 18 Dic 2003 23 Jun 2005 Sherman Michael C. Designed composite degradation for spinal implants
US20050137715 1 Dic 2004 23 Jun 2005 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050177144 1 Dic 2004 11 Ago 2005 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050177245 7 Feb 2005 11 Ago 2005 Leatherbury Neil C. Absorbable orthopedic implants
US20050182411 17 Feb 2004 18 Ago 2005 Demeo Joseph Oriented polymer implantable device and process for making same
US20050182428 17 Feb 2004 18 Ago 2005 The Regents Of The University Of California System for closure of a physical anomaly
US20050197422 3 Mar 2005 8 Sep 2005 Mayadunne Roshan T.A. Biocompatible polymer compositions for dual or multi staged curing
US20050208094 7 Sep 2004 22 Sep 2005 Armitage Bryan M Bone cement compositions having fiber-reinforcement and/or increased flowability
US20050240281 31 Ago 2004 27 Oct 2005 Slivka Michael A Fiber-reinforced, porous, biodegradable implant device
US20050273106 6 Jun 2005 8 Dic 2005 Oepen Randolf V Self foreshortnening fastener
US20060027612 30 Jun 2005 9 Feb 2006 Roiy Boaron Apparatus for wearing socks
US20060051394 24 Mar 2005 9 Mar 2006 Moore Timothy G Biodegradable polyurethane and polyurethane ureas
US20060067973 29 Ago 2005 30 Mar 2006 Schachter Deborah M Bone void filler
US20060121087 15 Nov 2005 8 Jun 2006 Williams Michael S Polymeric endoprostheses with modified erosion rates and methods of manufacture
US20060136071 23 Dic 2003 22 Jun 2006 Maspero Fabrizio A Biodegradable biocompatible implant
US20060177480 17 May 2005 10 Ago 2006 Hsing-Wen Sung Drug-eluting biodegradable stent
US20060178739 * 2 Feb 2006 10 Ago 2006 Shalaby Shalaby W Fiber-reinforced composite absorbable endoureteral stent
US20060188546 18 Nov 2003 24 Ago 2006 Polymerix Corporation Medical devices employing novel polymers
US20060188547 20 Oct 2005 24 Ago 2006 Bezwada Biomedical, Llc Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices
US20060200150 1 Mar 2005 7 Sep 2006 Jouko Ilomaki Bone screw and driver system
US20060247610 28 Abr 2005 2 Nov 2006 Janel Lanphere Tissue-treatment methods
US20060263335 29 Mar 2004 23 Nov 2006 Regentec Ltd. Porous matrix
US20060264948 21 Abr 2006 23 Nov 2006 Williams Lytton A Bone anchored surgical mesh
US20060293749 1 Jun 2006 28 Dic 2006 Zimmer Spine, Inc. Interbody fusion ring and method of using the same
US20070014831 12 Jul 2005 18 Ene 2007 Hsing-Wen Sung Biodegradable occlusive device with moisture memory
US20070043376 2 Dic 2005 22 Feb 2007 Osteobiologics, Inc. Bone and cartilage implant delivery device
US20070048383 25 Ago 2005 1 Mar 2007 Helmus Michael N Self-assembled endovascular structures
US20070050018 1 Sep 2005 1 Mar 2007 John Wainwright Biodegradable stents
US20070065652 12 Mar 2004 22 Mar 2007 Willaim Marsh Rice University Composite injectable and pre-fabricated bone replacement material and method for the production of such bone replacement material
US20070067043 19 Sep 2005 22 Mar 2007 Dericks Gerard H "Cement and bone graft absorbable & implantable detachable sac," a delivery system
US20070083205 26 Sep 2005 12 Abr 2007 Mohamed Attawia Tissue augmentation, stabilization and regeneration Technique
US20070128154 6 Dic 2006 7 Jun 2007 Tyco Healthcare Group Lp Bioabsorbable surgical composition
US20070134305 7 Dic 2006 14 Jun 2007 Ramot At Tel Aviv University Ltd. Drug-delivering composite structures
US20070141111 20 Ago 2004 21 Jun 2007 Bioretec Oy Porous medical device and method for its manufacture
US20070156251 23 Nov 2006 5 Jul 2007 Ben-Zion Karmon Bioresorbable Inflatable Devices, Incision Tool And Method For Tissue Expansion And Tissue Regeneration
US20070182041 6 Feb 2007 9 Ago 2007 Tepha, Inc. Toughened Polylactic Acid Polymers and Copolymers
US20070191963 19 Ene 2007 16 Ago 2007 John Winterbottom Injectable and moldable bone substitute materials
US20070260324 4 May 2007 8 Nov 2007 Joshi Ashok V Fully or Partially Bioresorbable Orthopedic Implant
US20070265622 8 Jun 2007 15 Nov 2007 Woodwelding Ag Implants for creating connections to tissue parts, in particular to skeletal parts, as well as device and method for implantation thereof
US20070270852 17 Jul 2006 22 Nov 2007 Pertti Tormala Bioabsorbable, deformable fixation material and implant
US20070276366 11 May 2006 29 Nov 2007 Gaines Robert W Jr Use of bioabsorbable materials for anterior extradiscal correction of thoracolumbar pathologies
US20070280983 1 Jun 2006 6 Dic 2007 Strickler Frederick H Medical devices having improved performance
US20070299151 5 Nov 2005 27 Dic 2007 Guelcher Scott A Degradable Polyurethane Foams
US20070299156 22 Dic 2004 27 Dic 2007 Smith & Nephew, Plc Tunable Segmented Polyacetal
US20070299449 6 Jun 2007 27 Dic 2007 Bioretec Oy Bone fixation device
US20080077140 26 Sep 2007 27 Mar 2008 Osman Said G Biologic Intramedullary Fixation Device and Methods of Use
US20080085297 6 Oct 2006 10 Abr 2008 Vipul Dave Bioabsorbable device having encapsulated additives for accelerating degradation
US20080086199 6 Oct 2006 10 Abr 2008 Vipul Dave Bioabsorbable device having composite structure for accelerating degradation
US20080154368 21 Dic 2006 26 Jun 2008 Warsaw Orthopedic, Inc. Curable orthopedic implant devices configured to harden after placement in vivo by application of a cure-initiating energy before insertion
US20080154373 21 Dic 2006 26 Jun 2008 Warsaw Orthopedic, Inc. Curable orthopedic implant devices configured to be hardened after placement in vivo
US20080200638 1 Ago 2005 21 Ago 2008 Jody Redepenning Bioresorbable Composites and Method of Formation Thereof
US20080206297 28 Feb 2008 28 Ago 2008 Roeder Ryan K Porous composite biomaterials and related methods
US20080228186 3 Abr 2006 18 Sep 2008 The Regents Of The University Of Colorado Graft Fixation Device
US20080234754 13 Abr 2007 25 Sep 2008 University Of Massachusetts - Lowell Novel biodegradable bone plates and bonding systems
US20080234762 6 Mar 2007 25 Sep 2008 Zimmer Technology, Inc. Self-tapping screw with resorbable tip
US20080249633 22 Ago 2007 9 Oct 2008 Tim Wu Biodegradable Materials and Methods of Use
US20080262613 26 Jul 2004 23 Oct 2008 Sylwester Gogolewski Biocompatible, Biodegradable Polyurethane Materials With Controlled Hydrophobic to Hydrophilic Ratio
US20080305144 16 Ago 2006 11 Dic 2008 Brown Malcolm Nmi High Strength Devices and Composites
US20090030160 14 Mar 2006 29 Ene 2009 Shinichi Kanazawa Polylactic Acid Complex and Production Method Thereof
US20090048145 9 Jun 2005 19 Feb 2009 Scil Technology Gmbh In situ hardening paste, its manufacturing and use
US20090093888 5 Oct 2007 9 Abr 2009 Zimmer Spine, Inc. Medical implant formed from porous metal and method
US20090099600 3 Oct 2008 16 Abr 2009 Timothy Graeme Moore High modulus polyurethane and polyurethane/urea compositions
US20090149856 5 Dic 2008 11 Jun 2009 Bioretec Oy Medical device and its manufacture
US20090171064 18 Jun 2007 2 Jul 2009 Gunze Limited Bio-degradable/ absorbable polymer having reduced metal catalyst content, and process for production thereof
US20090204116 7 Feb 2009 13 Ago 2009 Shalaby Shalaby W Multiphasic absorbable compositions of segmented /-lactide copolymers
US20090270923 14 Jul 2006 29 Oct 2009 Bioretec Oy Bioabsorbable band system,a bioabsorbable band, a method for producing a bioabsorbable band, a needle system of a bioabsorbable band and a locking mechanism
US20090274742 16 Ago 2006 5 Nov 2009 Brown Malcolm Nmi Multimodal high strength devices and composites
AU2008240418B2 Título no disponible
CA2254002A1 12 Nov 1998 12 May 2000 Takiron Co., Ltd. Shape-memory, biodegradable and absorbable material
CN1857742A 30 Abr 2005 8 Nov 2006 中国科学院金属研究所 Biomedicine implant material with controllable degrading rate and its application
DE1604403B1 21 Abr 1966 26 Nov 1970 Francine Adany Verfahren und Vorrichtung zum Herstellen eines Schrumpfschlauches aus thermoplastischem Kunststoff
DE2817778A1 22 Abr 1978 23 Nov 1978 Firestone Tire & Rubber Co Glasfaserverstaerkte polyamidzusammensetzungen
DE2947985A1 28 Nov 1979 17 Sep 1981 Vnii Ispytatel Med Tech Matrix material for fixing bone fractures - consisting of a copolymer of hydrophilic and hydrophobic monomers reinforced with resorbable non-non-toxic fibres
DE3036611A1 29 Sep 1980 9 Jun 1982 Kabel Metallwerke Ghh Sealed connection esp. between cable and duct - produced using hot-shrink thermoplastics tube which shrinks at one end and expands at the other
DE3936188A1 31 Oct 1989 3 May 1990 Boehringer Ingelheim Kg Continuous prodn. of bio:absorbable polyester(s) - by polymerisation in temp.-controlled extruder
DE4220216C1 20 Jun 1992 13 Ene 1994 S & G Implants Gmbh Endoprosthesis - has bio-resorbable distance rings to set gap between prosthesis and bone
DE4226465A1 10 Ago 1992 11 Feb 1993 Gunze Kk Material for maxillary reconstruction - is produced from biodegradable and bio-absorbable polymer, e.g. poly:lactic acid
DE102005032005A1 8 Jul 2005 11 Ene 2007 Adolf Pfaff Dr. Karl-Friedrich Reichenbach Gbr (Vertretungsberechtigter Gesellschafter: Adolf Pfaff, 79183 Waldkirch) Filling material pin for filling a tooth root canal is made from a flexible memory material which expands on heating to a specified temperature
EP0204931A1 21 Abr 1986 17 Dic 1986 Biocon Oy Resorbable surgical composite material and method of producing it
EP0299004A1 2 Ago 1988 18 Ene 1989 Materials Consultants Oy Surgical composite and use of a composite for manufacturing (part of) a device for use in bone surgery.
EP0321389A1 14 Dic 1988 21 Jun 1989 Mecron Medizinische Produkte Gmbh Implantable prosthesis
EP0326426A2 27 Ene 1989 2 Ago 1989 JMS Co., Ltd. Plastic molded articles with shape memory property
EP0326426B1 27 Ene 1989 21 Dic 1994 JMS Co., Ltd. Plastic molded articles with shape memory property
EP0401844A2 8 Jun 1990 12 Dic 1990 Boehringer Ingelheim Kg Resorbable moulded articles and method for their preparation
EP0404004A2 18 Jun 1990 27 Dic 1990 Nippon Unicar Company Limited A shape memory elastic body
EP0439892A2 27 Abr 1990 7 Ago 1991 Kingston Technologies, Inc. Amorphous memory polymer alignment device
EP0475077A2 7 Ago 1991 18 Mar 1992 Synthes AG, Chur Bone regeneration membrane
EP0531487A1 26 Mar 1992 17 Mar 1993 Uwe Storch Use of a mixture to produce medical implants.
EP0590656A1 29 Sep 1993 6 Abr 1994 UNION CARBIDE CHEMICALS &amp; PLASTICS TECHNOLOGY CORPORATION Method for improving the mechanical performance of composite articles
EP0595956A1 21 Jul 1992 11 May 1994 ELTING, James System for performing hip prosthesis revision surgery
EP0635274A2 15 Jul 1994 25 Ene 1995 United States Surgical Corporation Plasticizers for fibers used to form surgical devices
EP0711534A1 29 Sep 1995 15 May 1996 Didier Dr. Prost Femoral stem for prosthesis
EP0747072A2 7 May 1996 11 Dic 1996 United States Surgical Corporation Biodegradable moldable surgical material
EP0751165A2 1 Jul 1996 2 Ene 1997 Ethicon, Inc. High strength, fast absorbing, melt processable, glycolide-rich, poly(glycolide-co-p-dioxanone) copolymers
EP0803521A1 22 Abr 1997 29 Oct 1997 Nippon Shokubai Co., Ltd. Block copolymer and its production process and use
EP0805175A1 29 Abr 1997 5 Nov 1997 Kureha Kagaku Kogyo Kabushiki Kaisha Oriented polyglycolic acid film and production process thereof
EP0806283A2 8 May 1997 12 Nov 1997 Kureha Kagaku Kogyo Kabushiki Kaisha Stretch blow molded container and production process thereof
EP0815809A2 27 Jun 1997 7 Ene 1998 Johnson &amp; Johnson Professional, Inc. Prosthesis with variable fit and strain distribution
EP1000958A1 12 Nov 1998 17 May 2000 Takiron Co. Ltd. Shape-memory, biodegradable and absorbable material
EP1009448A2 27 Ago 1998 21 Jun 2000 Bionx Implants Oy Bioactive and biodegradable composites of polymers and ceramics or glasses and method to manufacture such composites
EP1056487A1 23 Feb 1999 6 Dic 2000 Massachusetts Institute Of Technology Biodegradable shape memory polymers
EP1086711A1 20 Sep 2000 28 Mar 2001 IsoTis N.V. Ceramic-polymer composites
EP1093774A1 21 Oct 1999 25 Abr 2001 Karl Storz GmbH &amp; Co. KG Interference screw
EP1136510A1 23 Mar 2001 26 Sep 2001 Ethicon, Inc. Thermoformed bioabsorbable polymers for use in medical devices
EP1142597A1 7 May 1996 10 Oct 2001 United States Surgical Corporation Biodegradable moldable surgical material
EP1216717A1 21 Dic 2001 26 Jun 2002 Ethicon Inc. Reinforced tissue implants and methods of manufacture and use
EP1277482A2 17 Mar 2000 22 Ene 2003 The Regents Of The University Of Michigan Mineralization and cellular patterning on biomaterial surfaces
EP1284756A1 31 May 2001 26 Feb 2003 Mnemoscience GmbH Shape memory thermoplastics and polymer networks for tissue engineering
FR2691901A1 Título no disponible
FR2691991A1 Título no disponible
FR2863478A1 Título no disponible
GB807589A Título no disponible
GB1416575A Título no disponible
GB2215209A Título no disponible
JP2003094516A Título no disponible
JP2003518230A Título no disponible
JP2006503172A Título no disponible
JP2007046050A Título no disponible
JPH0321613Y2 Título no disponible
JPH0665460U Título no disponible
JPH0940761A Título no disponible
JPH0995606A Título no disponible
JPH01192367A Título no disponible
JPH02169612A Título no disponible
JPH02270519A Título no disponible
JPH05147105A Título no disponible
JPH06234157A Título no disponible
JPH8196617A Título no disponible
JPH09221539A Título no disponible
JPH09234241A Título no disponible
JPH09272790A Título no disponible
JPH10176039A Título no disponible
JPH10309313A Título no disponible
JPH11209595A Título no disponible
JPS62199429U Título no disponible
KR0180858B1 Título no disponible
WO1984004311A1 16 Abr 1984 8 Nov 1984 Hexcel Corp Lactide/caprolactone polymer, method of making the same, composites thereof, and prostheses produced therefrom
WO1990003768A1 27 Sep 1989 19 Abr 1990 Southern Research Institute Biodegradable in-situ forming implants
WO1993001773A1 21 Jul 1992 4 Feb 1993 Mikhail Michael W E System for performing hip prosthesis revision surgery
WO1995034331A1 22 May 1995 21 Dic 1995 Ao-Forschungsinstitut Davos Self-expanding, adaptable cavity plug for use in implantation of endo-joint prosthesis
WO1996022061A1 19 Ene 1996 25 Jul 1996 Jeffcoat Robert L Elastically stabilized endosseous dental implant
WO1997005193A1 24 Jul 1996 13 Feb 1997 Sanitaria Scaligera Spa A process of surface activation of biocompatible and bioabsorbable aliphatic polyesters and polyesters thus activated
WO1997025936A1 8 Ene 1997 24 Jul 1997 Cambridge Scientific, Inc. Buffered resorbable internal fixation devices for repair of bone fractures
WO1997029673A1 14 Feb 1997 21 Ago 1997 Pressalit A/S A toilet cover assembly with damper
WO1997036555A1 27 Mar 1997 9 Oct 1997 Cambridge Scientific, Inc. Material for buffered resorbable internal fixation devices and method for making same
WO1998000141A1 27 Jun 1997 8 Ene 1998 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-trihexyphenidyl
WO1998026814A1 16 Dic 1997 25 Jun 1998 Jvs-Polymers Oy Plasticizable implant material
WO1998030141A3 8 Ene 1998 26 Nov 1998 Cohesion Tech Inc Devices for tissue repair and methods for preparation and use thereof
WO1998047445A1 16 Abr 1998 29 Oct 1998 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
WO1999011296A3 27 Ago 1998 24 Jun 1999 Bionx Implants Oy Bioactive and biodegradable composites of polymers and ceramics or glasses
WO1999011297A2 19 Ago 1998 11 Mar 1999 Btg International Limited Biodegradable composites
WO1999022770A1 23 Ene 1998 14 May 1999 Shearwater Polymers, Inc. Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
WO2000001426A1 5 Jul 1999 13 Ene 2000 Smith & Nephew Plc Blend of bioresorbable polymers
WO2001046501A3 29 Nov 2000 21 Feb 2002 Kimberly Clark Co Synthetic fiber
WO2001096105A3 16 May 2001 7 Mar 2002 Owens Corning Fiberglass Corp Moldable matrix polymer material and method for making molded composite product
WO2002000137A1 26 Feb 2001 3 Ene 2002 Shukla Atul J Biodegradable vehicles and delivery systems of biologically active substances
WO2002034159A3 23 Oct 2001 28 Nov 2002 Bradley J Coates Non-metallic implant devices and intra-operative methods for assembly and fixation
WO2002034310B1 23 Oct 2001 20 Feb 2003 Sdgi Holdings Inc Self-forming orthopedic implants
WO2002076725A1 14 Mar 2002 3 Oct 2002 Sicc (Special Industrials Coating Company) Polyurethane in intimate contact with fibrous material
WO2003057844A2 31 Dic 2002 17 Jul 2003 The Regents Of The University Of Michigan Tissue engineering scaffolds
WO2003064531A1 31 Ene 2003 7 Ago 2003 Smith & Nephew Plc High strength bioresorbables containing poly-glycolic acid
WO2004011054A3 28 Jul 2003 1 Abr 2004 Alza Corp Injectable multimodal polymer depot compositions and uses thereof
WO2004071356A3 10 Feb 2004 23 Dic 2004 David C Kelman Resorbable devices
WO2004110313A1 9 Jun 2004 23 Dic 2004 Mnemoscience Gmbh Stents
WO2005014718A1 19 Jul 2004 17 Feb 2005 Smith & Nephew Plc High strength bioreabsorbable co-polymers
WO2005028534A1 16 Ago 2004 31 Mar 2005 Mnemoscience Gmbh Amorphous polyester urethane networks having shape memory properties
WO2005046470A1 8 Nov 2004 26 May 2005 The Regents Of The University Of Colorado, A Body Corporate Shape-memory polymer coated electrodes
WO2005085313A1 3 Mar 2005 15 Sep 2005 Commonwealth Scientific And Industrial Research Organisation Polymer compositions for dual or multi staged curing
WO2005112804A9 20 May 2005 23 Mar 2006 Myers Surgical Solutions Llc Fracture fixation and site stabilization system
WO2006053936A1 3 Nov 2005 26 May 2006 Jvs-Polymers Oy Crosslinkable biopolymer
WO2006064025A3 14 Dic 2005 24 Ago 2006 Fidia Advanced Biopolymers Srl A biocompatible material and a prosthetic device made thereof for the replacement, repair and regeneration of meniscus
WO2006095138A1 1 Mar 2006 14 Sep 2006 H Young (Operations) Limited Security system
WO2006108114A2 3 Abr 2006 12 Oct 2006 The Regents Of The University Of Colorado A graft fixation device and method
WO2006114483A3 27 Abr 2006 1 Mar 2007 Nureddin Ashammakhi A bioabsorbable and bioactive composite material and a method for manufacturing the composite
WO2006116129A3 21 Abr 2006 19 Abr 2007 Micardia Corp Dynamically adjustable implants and methods for reshaping tissue
WO2007020430A2 16 Ago 2006 22 Feb 2007 Smith & Nephew, Plc Multimodal high strength devices and composites
WO2007020432A3 16 Ago 2006 21 Dic 2007 Malcolm Brown High strength devices and composites
WO2007021593A3 3 Ago 2006 3 Ene 2008 Cedars Sinai Medical Center Bio-absorbable stent
WO2007023296A1 25 Ago 2006 1 Mar 2007 West Hertfordshire Hospitals Nhs Trust Surgical scaffold
WO2007024492A3 9 Ago 2006 10 Ene 2008 Medtronic Vascular Inc Medical devices and coatings therefore comprising biodegradable polymers with enhanced functionality
WO2007038009A2 14 Sep 2006 5 Abr 2007 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique
WO2007065074A3 22 Nov 2006 9 Ago 2007 Univ Indiana Res & Tech Corp Biodegradable implant polymers and composites
WO2007084609A3 19 Ene 2007 24 Ene 2008 Osteotech Inc Porous osteoimplant
WO2007086832A2 13 Ene 2006 2 Ago 2007 Biodynamics, L.L.C Surgical fasteners and related implant devices having bioabsorbable components
WO2007111808A3 5 Mar 2007 7 Ago 2008 Boston Scient Scimed Inc Medical devices having biodegradable polymeric regions
WO2007117499A2 5 Abr 2007 18 Oct 2007 University Of Nebraska Bioresorbable polymer reconstituted bone and methods of formation thereof
WO2008001633A1 18 Jun 2007 3 Ene 2008 Gunze Limited Bio-degradable/absorbable polymer having reduced metal catalyst content, and process for production thereof
WO2008044011A2 8 Oct 2007 17 Abr 2008 Mohamed Khalid Intramedulleray fixation device
WO2008067531A3 30 Nov 2007 2 Oct 2008 Smith & Nephew Inc Fiber reinforced composite material
WO2008089172A2 15 Ene 2008 24 Jul 2008 University Of Massachusetts-Lowell Novel biodegradable bone plates and bonding systems
WO2008098019A3 5 Feb 2008 7 May 2009 Carbylan Biosurgery Inc Polymer formulations for delivery of bioactive agents
WO2008101932A2 19 Feb 2008 28 Ago 2008 National University Of Ireland, Galway Porous substrates for implantation
WO2008112875A2 13 Mar 2008 18 Sep 2008 Smith & Nephew, Inc. Internal fixation devices
WO2008112880A2 13 Mar 2008 18 Sep 2008 Smith & Nephew, Inc. Systems and methods for installing and removing an expandable polymer
WO2008112912A3 13 Mar 2008 3 Sep 2009 Smith & Nephew, Inc. Internal fixation devices
WO2008116591A2 19 Mar 2008 2 Oct 2008 Stryker Trauma Gmbh Implantation device, method for producing and for applying the same
WO2008131197A1 18 Abr 2008 30 Oct 2008 Smith & Nephew, Inc. Multi-modal shape memory polymers
WO2008134264A1 18 Abr 2008 6 Nov 2008 Synthes Usa, Llc Implant devices constructed with metallic and polymeric components
1 Andriano, et al., 'Processing and characterization of absorbable polylactide polymers for use in surgical implants,' Journal of Applied Biomaterials, 5(2):133-140 (1994).
2 Asano, et al., 'In vivo characteristics of low molecular weight copoly(D.L-lactic acid) formulations with controlled release of LH-RH agonist,' Biomaterials, 10(8):569-573 (1989).
3 Atkins, G.J. et al. "Role of polyethylene particles in peri-prosthetic osteolysis: A Review." World of Journals of Orthopedics, 2(10), Oct. 18, 2011, pp. 93-101.
4 Australian Examiner's First Report on patent application AU 2008240418 dated Dec. 2, 2011.
5 Australian Office Action regarding Australian Patent Application No. 2008240418 dated Dec. 2, 2011.
6 Barca, et al., 'Resorbable poly-L-lactic acid mini-staples for the fixation of Akin osteotomies,' The Journal of Foot and Ankle Surgery, 36(2):106-111 (1997).
7 Bartenev et al.; On the theory of biaxial orientation of amorphous polymers, Mechanics of Composite Materials, 1973, vol. 6, p. 671-677.
8 Bertrand, et al., Biocompatibility Aspects of New Stent Technology, JACC, 32(3):562-571 (1998).
9 Celikkaya, et al., 'Poly(DL-lactide)/Poly(ethylene glycol) Copolymer Particles. I. Preparation and Characterization,' Journal of Applied Polymer Science, 61: 1439-1446 (1996).
10 D. Hull and T. W. Clyne, 'An introduction to composite materials,' Second Edition, Cambridge University Press, Table of Contents, (1996) 8 pages.
11 D. Wheeler, et al., 'Effect of bioactive glass particle size on osseous regeneration of cancellous defects,' J. Biomed. Materials Research, 41(4):527-533 (1998).
12 Daniels, et al., 'Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone,' J. Applied Biomaterials, 1 :57-78 (1990).
13 Dauner, et al. 'Resorbable continuous-fiber reinforced polymers for osteosynthesis,' J. Materials Science Materials in Medicine, 9: 173-179 (1998).
14 Eling, et al., 'Biodegradable Materials of Poly(L-Lactic Acid): 1. Melt-Spun and Solution-Spun Fibres,' Polymer, 23:1587-1593 (1982).
15 Fambri, et al., 'Biodegradable fibres of poly(l-lactic acid) produced by melt spinning,' Polymer, 38:79-85 (1997).
16 Frenger, 'Biomedical Uses of Shape Memory Polymers,' Biomed. Sci. Instrum., 29:47-50 (1993).
17 Fukuzaki, et al., Synthesis of copoly(D,L-Lactic acid) with relatively low molecular weight and in vitro degradation, Japan Atomic Energy Research Institute, Gunma, Jpn, European Polymer Journal,25(10):1019-1026 (1989).
18 Gautier, et al., 'Poly(a-hydroxyacids) for application in the spinal cord: Resorbability and biocompatibility with adult rate Schwann cells and spinal cord,' Journal of Biomedical Materials Research, 42(4):642-654 (1998).
19 Giardino, et al., 'Experimental evaluation of a resorbable intramedullary plug for cemented total hip replacement,' Biomaterials, 18(13):907-913 (1997).
20 Gogolewsji, et al., 'Resorbable materials of poly(L-lactide). II Fibers spun from solutions of poly(L-lactide) in good solvents,' J. Appl. Polymer Sci., 28:1045-1061 (1983).
21 Grijpma et al., 'Chain Entanglement Mechanical Properties and Drawability of Poly (Lactide),' Colloid Polym Sci., 272: 1068-1081 (1994).
22 Haers, et al., 'Biodegradable polyactide plates and screws in orthognathic surgery,' Technical Note, Journal of Cranio-Maxillofacial Surgery, 26(2):87-91 (1998).
23 Hill, R.G., "Chapter 10: Biomedical Polymers." Biomaterials, artificial organs and tissue engineering. Imperial College London, UK (2005), 7 pages. [copy unavailable].
24 Hyon, et al., 'Effects of residual monomer on the degradation of DL-lactide polymer,' Hyon, Jamshidi & Ikada, Polymer International, 46:196-202 (1998).
25 International Search Report and Written Opinion for PCT/GB2008/001331 dated Aug. 25, 2008.
26 J. West et al, 'Bioactive Polymers, Synthetic biodegradable polymer scaffolds,' Chapter 5, pp. 83-95, Anthony Atala and David J. Mooney, Editors; Joseph P. Vacanti and Robert Langer, Associate Editors, Birkhauser (1997).
27 Japanese 1st Office Action for Application No. 2010-503579, dated Mar. 6, 2012, 6 pages.
28 Japanese 2nd Office Action for Application No. 2010-503579, dated Feb. 19, 2013, 3 pages.
29 Kaitian, et al., 'Poly(D,L-Lactic Acid) Homopolymers: Synthesis and Characterization,' Turkish Journal of Chemistry, 20:43-53 (1996).
30 Kister, et al., 'Effects of morphology, conformation and configuration on the IR and Raman spectra of various poly(lactic acid)s,' Polymer, 39(2): 267-273 (1998).
31 Koelling, et al., 'In vitro real-time aging and characterization of poly(L/D-lactic acid),' Proceedings of the 1997 1ffh Southern Biomedical Engineering Conference (Cat. No. 97TH8270), pp. 197-201.
32 Kontio, et al., 'Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymers implants: study of the expression of tenascin and cellular fibronectin,' Journal of Materials Science-Materials in Medicine, 9:10:603-609 (1988).
33 Kricheldorf, et al., 'Polyactones: 32. High-molecular weight polylactides by ring-opening polymerization with dibutylmagnesium or butylmagnesium chloride,' Polymer, 36(15):2995-3003 (1995).
34 L. L. Hench, 'Bioactive materials: The potential for tissue regeneration,' J. Biomed. Materials Research, 41(4):511-518 (1998).
35 Losken, et al., 'Memory of DL-polylactic acid biodegradable plates,' Ann. Plast. Surg., 32(6):606-611 (1994).
36 MacDonald, et al., 'Enzymatic degradability of poly(lactide): Effects of chain stereochemistry and material crystallinity,' Macromolecules, 29(23):7356-7361 (1996).
37 Mainil-Varlet, et al., 'Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular weight polylactides,' Journal of Biomedical Materials Research, 36(3):360-380 (1997).
38 Matsumura, et al., 'Novel ring opening polymerization of lactide by lipase,' Macromol. Symp., 130:285-304 (1998).
39 Mauduit, J. et al.; "Hydrolytic degradation of films prepared from blends of high and low molecular weight poly (DL lactic acid)s" Journal of Biomedical Materials Research, 1996, vol. 30, p. 201-207.
40 Momma, M. et al. "Long Bone Intramedullary Fixation Method Using Shape Memory Anchoring Nails-An Attempt at a Biomechanical Test and the Application Thereof to Proximal Humeral Fractures." J. Eastern Japan Assoc. Orthopaedics & Traumatology, vol. 12, No. 4: 385-90.
41 Morita, et al., 'Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants,' Biological & Pharmaceutical Bulletin, 21 (2): 188-190 (1998).
42 Nativ, O. et al. "Bladder neck suspension using bone anchors for the treatment of female stress incontinence." ASAIO J. May-Jun. 1997;43(3):204-8.
43 Office Action from related European Application No. 08736993.0-1706 dated Mar. 10, 2017.
44 Okihara, et al., Crystal structure of stereocomplex of poly(L-lactide) and poly(D-lactide), Journal of Macromolecular Science-Physics, B30(1 and 2): 119-140 (1991).
45 Okuzaki, et al., Mechanical Properties and Structure of the Zone-Drawn Poly(l-lactic acid) Fibers, Journal of Polymer Science, Part B, Polymer Physics, 37:991-996 (1999).
46 Oriented Polymer Materials, Edited by Stoyko Fakirov, published by Huthig & Wepf Verlag Zug, Heidelberg, Oxford CTIUSA, Table of Contents pp. v, viii, ix-xix (1996).
47 PCT/GB2008/001331 International Preliminary Report on Patentability with Written Opinion dated Oct. 20, 2009, 8 pages.
48 Penning, et al., 'Preparation and properties of absorbable fibres from l-lactide copolymers,' Polymer, 34(5):942-951 (1993).
49 Pitt, et al., 'Modification of the rates of chain cleavage of polY(e-caprolactone) and related polyesters in the solid state,' Journal of Controlled Release, 4:283-292 (1987).
50 Pitto, et al., "Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty," J. Bone Joint Surg., 81-A(6)˜831-843 (1999).
51 Rak, et al., 'The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier,' (1985) liverpool Poly tech., liverpool, UK, Pharmaceutica Acta Helvetiae, 60:(5-6):162-169.
52 Ristic, et al., 'An investigation of synthesis and degradation of poly(D,L-lactide) and controlled release of albumin from biodegradable poly(D,L-lactide) cylinders,' ICheaP-2, the second Italian conference on chemical and process engineering, Florence, pp. 559-563 (1995).
53 Schliephake, et al., 'Reconstruction of the mandible by prefabricated autogenous bone grafts,' Int. J. Oral Maxillofac. Surg., 26:244-252 (1997).
54 Siparsky, G.L. et al. "Water Transport in Polylactic Acid (PLA)." Journal of Environmental Polymer Degradation, vol. 5, No. 3, 1997.
55 * Song et al ("Double buble tubular film extrusion of polybutylene terephthalate-polyethylene terephthalate blends", Publication of Society of Plastic Engineers, Dec. 1999).
56 Stahelin, et al., Clinical degradation and biocompatibility of different bioabsorbable interference screws: a report of six cases: Arthroscopy: The Journal of Arthroscopic & Related Surgery, 13(2):238-244 (1997).
57 Steendam, et al., The role of elastic relaxation in drug delivery from poly(DL-lactic acid) based tablets. A shape memory phenomenon: Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 25:128-129 (1998).
58 Stevels, et al., 'Blends van blok copolymeren die een poly(L-lactide) of poly(D-lactide) blok bevatten,' Biomedical Science and Engineering Meeting, pp. 107-110 (1994).
59 Structure and Properties of Oriented Polymers, Ed. I. M. Ward, Department of Physics, UniverSity of Leads, England, a Halsted Press Book, John Wiley & Sons, New York-Toronto (1975) Table of Contents.
60 Summary of the Office Action, dated Mar. 19, 2012, 1 page.
61 Tagl, "Thesis-The morselized and impacted bone graft animal experiments on proteins, impaction and load," Acta Orthop. Scand. Suppl., 290:1-40 (2000).
62 Temenoff et al., "Injectable biodegradable materials for orthopedic tissue engineering," Biomaterials, 21 :2405-2412 (2000).
63 Tschakaloff, et al., 'Degradation kinetics of biodegradable DL-polyactic acid biodegradable implants depending on the site of implantation,' International Journal of Oral and Maxillofacial Surgery, 23(6 Pt2 ):443-445 (1994).
64 Tsuji, et al., Stereocomplex formation between enantiomeric poly(lactic acid). VIII. Complex fibers spun from mixed solution of poly(D-lactic acid) and poly(L-lactic acid), Journal of Applied Polymer Science, 51(2):337-344 (1994).
65 Vert, M. et al. "Bioresorbability and biocompatibility of aliphatic polyesters", Journal of Materials Science: Materials in Medicine 3, 1992, pp. 432-446.
66 Zegzula, et al., 'Bone Formation with Use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2,' The Journal of Bone and Joint Surgery, 79:1778-1790 (1997).
67 Zhang, Biodegradable lactide polymers: synthesis, degradation, and controlled drug release properties (drug release), Queen's University at Kingston, Canada, vol. 55/01-B of Dissertation Abstracts International, p. i-xv, 1-179 (Oct. 1993).
Clasificación internacional B29C61/06, A61L31/14, C08L67/04, B29C61/00, B29C61/04
Clasificación cooperativa A61L31/14, B29C61/06, C08L67/04, B29C61/04, B29C61/006, A61L2400/16